Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02428504 · ClinicalTrials.gov registry record
Decision Making in End of Life as Individual Preferences
A clinical trial of Terminal Diseases, sponsored by St. Luke's-Roosevelt Hospital Center.
- Completed
- Registry status
- 148
- Enrollment target
- 1
- Study location
NCT02428504 is a study of Terminal Diseases that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 148 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02428504, a study of Terminal Diseases, has completed, sponsored by St. Luke's-Roosevelt Hospital Center.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
- 1
- Study location
Study Summary
It is not universal that terminally ill patients choose surrogate in the event of disagreement between the treating physician and the surrogate at the end of their lives. There are several factors that influence the terminally ill patient's decision to choose a decision maker at the end of his / life.
Conditions Studied
Study Locations (1)
New York
- St. Luke's Roosevelt Hospital Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02428504
The ClinicalTrials.gov registry entry for NCT02428504 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's-Roosevelt Hospital Center, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Terminal Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT02428504 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02428504 about?
NCT02428504 is a clinical study titled "Decision Making in End of Life as Individual Preferences". It is not universal that terminally ill patients choose surrogate in the event of disagreement between the treating physician and the surrogate at the end of their lives. There are several factors that influence the terminally ill patient's decision to choose a decision maker at the end of his / lif...
What is the current status of trial NCT02428504?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2012-06. Estimated completion is 2015-12.
What conditions does trial NCT02428504 study?
This clinical trial studies the following conditions: Terminal Diseases.
Who is sponsoring clinical trial NCT02428504?
This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02428504 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.